Keita Nakanishi

Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus

Masakazu Imamura, Keita Nakanishi, Takayuki Suzuki et al. · Bioorganic & Medicinal Chemistry · 2012 · 130 citations · Full text

Medicinal Chemistry, Biochemistry, Benzothiophene Structure +10

Clinical and Genetic Characteristics in Patients With Gitelman Syndrome

Junya Fujimura, Kandai Nozu, Tomohiko Yamamura et al. · Kidney International Reports · 2018 · 70 citations · Full text

Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome

Tomoko Horinouchi, Kandai Nozu, Tomohiko Yamamura et al. · Journal of the American Society of Nephrology · 2018 · 59 citations · Full text

Synthesis and biological evaluation of C-glucosides with azulene rings as selective SGLT2 inhibitors for the treatment of type 2 diabetes mellitus: Discovery of YM543

Kazuhiro Ikegai, Masakazu Imamura, Takayuki Suzuki et al. · Bioorganic & Medicinal Chemistry · 2013 · 50 citations · Full text

Biochemistry, Medicine, Diabetes +6

Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases

China Nagano, Kandai Nozu, Naoya Morisada et al. · Clinical and Experimental Nephrology · 2018 · 30 citations

Pair Analysis, Genetics, Genetic Epidemiology +16